Real-World Evaluation of Treatment Patterns Among Patients With Chronic-Phase Chronic Myeloid Leukemia (CMLCP) in a Large Community Oncology Setting

被引：0
|
作者：
Zackon, Ira [1 ]
McDermott, Courtney [2 ]
Beeks, April [1 ]
Wentworth, Chuck [1 ]
Guo, Jinhong [1 ]
Jadhav, Kejal [2 ]
Wei, David [2 ]
Damon, Andrea [2 ]
Sadek, Islam [2 ]
Benton, Christopher [3 ]
机构：
[1] Ontada, Boston, MA USA
[2] Novartis, E Hanover, NJ USA
[3] Rocky Mt Canc Ctr, Aurora, CO USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
CML; TKI; chronic phase; treatment patterns; real-world data;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CML-636
引用
收藏
页码：S381 / S381
页数：1
相关论文
共 50 条
  • [21] Can Chronic-Phase Chronic Myeloid Leukemia Patients Achieve Optimal and Durable Responses after Two Failed TKI Treatments? Real-World Evidence Data
    Breccia, Massimo
    ACTA HAEMATOLOGICA, 2019, 142 (02) : 61 - 63
  • [22] Predictors of Ponatinib Therapy Duration Among Real-World Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients in the US
    Mauro, Michael J.
    McGarry, Lisa J.
    Lustgarten, Stephanie
    Huang, Hui
    BLOOD, 2016, 128 (22)
  • [23] Population pharmacokinetics of imatinib in Iranian patients with chronic-phase chronic myeloid leukemia
    Golabchifar, Ali-Akbar
    Rezaee, Saeed
    Ghavamzadeh, Ardeshir
    Alimoghaddam, Kamran
    Dinan, Nahid Mobarghei
    Rouini, Mohammad-Reza
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 74 (01) : 85 - 93
  • [24] Tyrosine Kinase Inhibitor Treatment Patterns in Patients With Chronic-Phase Chronic Myeloid Leukemia: A Single Center Data From China
    Yuan, Meng-yao
    Zhang, Xiao-shuai
    Jiang, Qian
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2025, 25 (04): : e243 - e252
  • [25] Population pharmacokinetics of imatinib in Iranian patients with chronic-phase chronic myeloid leukemia
    Ali-Akbar Golabchifar
    Saeed Rezaee
    Ardeshir Ghavamzadeh
    Kamran Alimoghaddam
    Nahid Mobarghei Dinan
    Mohammad-Reza Rouini
    Cancer Chemotherapy and Pharmacology, 2014, 74 : 85 - 93
  • [26] Real World Analysis Of Duration Of TKI Treatment Among Patients With Chronic Myeloid Leukemia
    Henk, Henry J.
    Woloj, Mabel
    Shapiro, Mark
    Whiteley, Jennifer
    BLOOD, 2013, 122 (21)
  • [27] Results of Dasatinib Therapy in Patients With Early Chronic-Phase Chronic Myeloid Leukemia
    Cortes, Jorge E.
    Jones, Dan
    O'Brien, Susan
    Jabbour, Elias
    Ravandi, Farhad
    Koller, Charles
    Borthakur, Gautam
    Walker, Brenda
    Zhao, Weiqiang
    Shan, Jianqin
    Kantarjian, Hagop
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 398 - 404
  • [28] Real-World Evaluation of the Treatment Landscape for Chronic Lymphocytic Leukemia
    Smith, Timothy W.
    Owusu, Henry F.
    Wormser, David
    Woo, Janghee
    BLOOD, 2021, 138
  • [29] Assessment of treatment and monitoring patterns and subsequent outcomes among patients with chronic myeloid leukemia treated with imatinib in a community setting
    Saleh, Mansoor N.
    Haislip, Sally
    Sharpe, Joyce
    Hess, Tamara
    Gilmore, James
    Jackson, James
    Sail, Kavita R.
    Ericson, Solveig G.
    Chen, Lei
    CURRENT MEDICAL RESEARCH AND OPINION, 2014, 30 (04) : 529 - 536
  • [30] Real-World Bruton Tyrosine Kinase Inhibitor (BTKi) Treatment Patterns Among Patients with Chronic or Small Lymphocytic Leukemia (CLL/SLL) in US Community Oncology Practices
    Hou, Jing-Zhou
    Blanc, Simon
    Maglinte, Gregory A.
    Vasudevan, Anupama
    Rui, Anna
    Gart, Michael
    Hoa Pham
    Aton, Lindsay
    Wang, Brandon
    Choksi, Rushir
    BLOOD, 2023, 142
12345